Real-world Effectiveness and Cost-effectiveness of HFA-beclometasone Compared With ICS/LABA Combination Therapy

NCT01697722 · clinicaltrials.gov ↗

COMPLETED

Status

815377

Enrollment

NETWORK

Sponsor class

Conditions

Asthma

Interventions

DRUG: Extra-fine hydrofluoroalkane-beclometasone dipropionate
DRUG: ICS / LABA via separate pMDI and / or BAI inhalers

Sponsor

Research in Real-Life Ltd

Collaborators

[object Object]